Gilead: HIV/HCV No Co-Infection (NoCo) Program: Micro-Elimination of HCV in HIV-Infected and High-Risk HIV-Uninfected Populations

Gilead invites applications for its HIV or hepatitis C virus no co-infection programme – micro-elimination of HCV in HIV-infected and high-risk HIV-uninfected populations. This supports research focused on addressing the challenges associated with hepatitis C virus (HCV) elimination for individuals co-infected with HIV or in people at high risk for HIV infection.

Funding & Duration

Funding is worth up to USD $600,000 (approx AUD $808,000) per project for two to three years.


Academic institutions, community organisations, research networks and clinical investigators may apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.